Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels

Gene

Volumn 557, Issue 2, 2015, Pages 195-200

  Wu, Xianjin ^a,b   Zeng, Rong ^b   Wu, Shaoke ^b   Zhong, Jixin ^b   Yang, Lawei ^b   Xu, Junfa ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Key Laboratory for Medical Molecular Diagnostics of Guangdong Province   (China)

Author keywords

Breast cancer (BC); Expression; IsomiR; MicroRNA (miRNA)

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 21; MICRORNA 221; MICRORNA 25; MICRORNA 30E; UNCLASSIFIED DRUG; TRANSCRIPTOME;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACTIN FILAMENT; ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN CHROMOSOME; HUMAN TISSUE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RNA SEQUENCE; BREAST TUMOR; FEMALE; GENE ONTOLOGY; GENETICS; MAMMARY GLAND; METABOLISM;

BREAST NEOPLASMS; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MAMMARY GLANDS, HUMAN; MICRORNAS; TRANSCRIPTOME;

EID: 84920927717     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.12.030     Document Type: Article

References (45)

1. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
2. Augoff K., McCue B., Plow E.F., Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol. Cancer 2012, 11:5.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
5. Borel C., Antonarakis S.E. Functional genetic variation of human miRNAs and phenotypic consequences. Mamm. Genome 2008, 19:503-509.
6. Brase J.C., Johannes M., Schlomm T., Falth M., Haese A., Steuber T., Beissbarth T., Kuner R., Sultmann H. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 2011, 128:608-616.
7. Cho W.C.S. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 2010, 42:1273-1281.
8. Cloonan N., Wani S., Xu Q., Gu J., Lea K., Heater S., Barbacioru C., Steptoe A.L., Martin H.C., Nourbakhsh E., Krishnan K., Gardiner B., Wang X., Nones K., Steen J.A., Matigian N.A., Wood D.L., Kassahn K.S., Waddell N., Shepherd J., Lee C., Ichikawa J., McKernan K., Bramlett K., Kuersten S., Grimmond S.M. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 2011, 12:R126.
9. Dentelli P., Traversa M., Rosso A., Togliatto G., Olgasi C., Marchio C., Provero P., Lembo A., Bon G., Annaratone L., Sapino A., Falcioni R., Brizzi M.F. miR-221/222 control luminal breast cancer tumor progression by regulating different targets. Cell Cycle 2014, 13:1811-1826.
10. Dinami R., Ercolani C., Petti E., Piazza S., Ciani Y., Sestito R., Sacconi A., Biagioni F., le Sage C., Agami R., Benetti R., Mottolese M., Schneider C., Blandino G., Schoeftner S. miR-155 drives telomere fragility in human breast cancer by targeting TRF1. Cancer Res. 2014, 74:4145-4156.
11. Guo L., Chen F. A challenge for miRNA: multiple isomiRs in miRNAomics. Gene 2014, 544:1-7.
12. Guo L., Yang Q., Lu J., Li H., Ge Q., Gu W., Bai Y., Lu Z. A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing. PLoS One 2011, 6:e21072.
13. Guo L., Yang S., Zhao Y., Wu Q., Chen F. Dynamic evolution of mir-17-92 gene cluster and related miRNA gene families in vertebrates. Mol. Biol. Rep. 2013, 40:3147-3153.
14. Guo L., Zhao Y., Zhang H., Yang S., Chen F. Close association between paralogous multiple isomiRs and paralogous/orthologues miRNA sequences implicates dominant sequence selection across various animal species. Gene 2013, 527:624-629.
15. Hongay C.F., Grisafi P.L., Galitski T., Fink G.R. Antisense transcription controls cell fate in Saccharomyces cerevisiae. Cell 2006, 127:735-745.
16. Huang Z.H., Huang D., Ni S.J.A., Peng Z.L., Sheng W.Q., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127:118-126.
17. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 2009, 55:1944-1949.
18. Kondo N., Toyama T., Sugiura H., Fujii Y., Yamashita H. MicroRNA-206 expression is down-regulated in estrogen receptor a-positive human breast cancer. Cancer Res. 2008, 68:5004-5008.
19. Kozlowska E., Krzyzosiak W.J., Koscianska E. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs. Int. J. Mol. Sci. 2013, 14:16999-17016.
20. Lacey J.V., Devesa S.S., Brinton L.A. Recent trends in breast cancer incidence and mortality. Environ. Mol. Mutagen. 2002, 39:82-88.
21. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
22. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
23. Madhavan D., Zucknick M., Wallwiener M., Cuk K., Modugno C., Scharpff M., Schott S., Heil J., Turchinovich A., Yang R., Benner A., Riethdorf S., Trumpp A., Sohn C., Pantel K., Schneeweiss A., Burwinkel B. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin. Cancer Res. 2012, 18:5972-5982.
24. Miller T.E., Ghoshal K., Ramaswamy B., et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol. Chem. 2008, 44:29897-29903.
25. Mulrane L., McGee S.F., Gallagher W.M., O'Connor D.P. miRNA dysregulation in breast cancer. Cancer Res. 2013, 73:6554-6562.
26. Neilsen C.T., Goodall G.J., Bracken C.P. IsomiRs - the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012, 28:544-549.
27. Ouzounova M., Vuong T., Ancey P.B., Ferrand M., Durand G., Le-Calvez Kelm F., Croce C., Matar C., Herceg Z., Hernandez-Vargas H. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 2013, 14:139.
28. Plasterk R.H.A. Micro RNAs in animal development. Cell 2006, 124:877-881.
29. Png K.J., Yoshida M., Zhang X.H., Shu W., Lee H., Rimner A., Chan T.A., Comen E., Andrade V.P., Kim S.W., King T.A., Hudis C.A., Norton L., Hicks J., Massague J., Tavazoie S.F. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 2011, 25:226-231.
30. Pongsavee M., Yamkamon V., Dakeng S., O-Charoenrat P., Smith D.R., Saunders G.F., Patmasiriwat P. The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor. Genet. Test. Mol. Biomarkers 2009, 13:307-317.
31. Qian B.Y., Katsaros D., Lu L.G., Preti M., Durando A., Arisio R., Mu L.N., Yu H. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta 1. Breast Cancer Res. Treat. 2009, 117:131-140.
32. Redova M., Sana J., Slaby O. Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol. 2013, 9:387-402.
33. Selcuklu S.D., Donoghue M.T.A., Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 2009, 37:918-925.
34. Sun Y., Wang M., Lin G., Sun S., Li X., Qi J., Li J. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One 2012, 7:e47003.
35. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
36. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., Konishi H., Morimura R., Deguchi K., Fujiwara H., Okamoto K., Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 2010, 102:1174-1179.
37. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.G.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
38. Volinia S., Galasso M., Sana M.E., Wise T.F., Palatini J., Huebner K., Croce C.M. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3024-3029.
39. Wang J., Wu J. Role of miR-155 in breast cancer. Front. Biosci. (Landmark Ed) 2012, 17:2350-2355.
40. Wang K., Zhang S.L., Marzolf B., Troisch P., Brightman A., Hu Z.Y., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4402-4407.
41. Wickramasinghe N.S., Manavalan T.T., Dougherty S.M., Riggs K.A., Li Y., Klinge C.M. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 2009, 37:2584-2595.
42. Wu Q., Wang C., Lu Z., Guo L., Ge Q. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin. Chim. Acta 2012, 413:1058-1065.
43. Yang Y., Chaerkady R., Beer M.A., Mendell J.T., Pandey A. Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009, 9:1374-1384.
44. Zhang C.M., Zhao J., Deng H.Y. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J. Biomed. Sci. 2013, 20:79.
45. Zhao R., Wu J., Jia W., Gong C., Yu F., Ren Z., Chen K., He J., Su F. Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie 2011, 34:675-680.